 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ZKY001 / Zhaoke Ophthalmology
ZKY001 With Different Concentrations in the Treatment of Corneal Epithelial Defect After Primary Pterygium Excision: A Multicenter, Randomized, Double-Masked Phase 2 Study (DEMAND) - Sep 24, 2024 - Abstract #AAO2024AAO_2046;
And the treatment-emergent adverse event rate was low (9.0%), with no significant difference . Conclusion ZKY001 can effectively improve CED and relieve foreign body sensation and pain after primary pterygium surgery, providing a new treatment for promoting corneal repairment and relieving discomfort.
- |||| ZKY001 / Zhaoke Ophthalmology
New P2 trial: ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase ? Clinical Trial (clinicaltrials.gov) - Jan 18, 2024
P2, N=180, Completed, Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- |||| ZKY001 / Zhaoke Ophthalmology
New P2 trial: TPRK: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops (clinicaltrials.gov) - Jan 16, 2024
P2, N=120, Completed, Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- || ZKY001 / Zhaoke Ophthalmology
Trial primary completion date: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects (clinicaltrials.gov) - Sep 17, 2021
P2, N=105, Recruiting, Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Conclusion ZKY001 can effectively improve CED and relieve foreign body sensation and pain after primary pterygium surgery, providing a new treatment for promoting corneal repairment and relieving discomfort. Trial primary completion date: Jan 2021 --> Dec 2021
- ||| ZKY001 / Zhaoke Ophthalmology
Enrollment open, Trial completion date, Trial primary completion date: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects (clinicaltrials.gov) - Jan 6, 2021
P2, N=105, Recruiting, Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Trial primary completion date: Jan 2021 --> Dec 2021 Not yet recruiting --> Recruiting | Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Oct 2020 --> Jan 2021
- || ZKY001 / Zhaoke Ophthalmology
Trial initiation date: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects (clinicaltrials.gov) - May 26, 2020
P2, N=105, Not yet recruiting, Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Not yet recruiting --> Recruiting | Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Oct 2020 --> Jan 2021 Initiation date: Apr 2020 --> Jul 2020
- | ZKY001 / Zhaoke Ophthalmology
New P2 trial: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects (clinicaltrials.gov) - Jan 13, 2020
P2, N=105, Not yet recruiting, Sponsor: Lee's Pharmaceutical Limited